GENE COMPANY

Owner

Goods & Services

Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology, namely, design and testing for new product development; design, engineering, research, and development services in the field of novel RNA nanoparticle technologies for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines

Diagnostic medical, biological, and pharmaceutical preparations for SARS, Flu, MRSA, Dengue, COPD, Idiopathic pulmonary fibrosis, liver failure, liver cancer, NASH, Stroke, Pancreatic cancer, oral squamous cell cancer, Acute myloid leukemia (AML), skin burn, skin scarring, skin aging, eye diseases such as vitreoretinal eye disease, and Macular degeneration, diabetes, obesity for medical laboratory use; vaccines; vaccine adjuvants; DIAGNOSTIC medical, biological, and pharmaceutical preparations for SARS, Flu, MRSA, Dengue, COPD, Idiopathic pulmonary fibrosis, liver failure, liver cancer, NASH, Stroke, Pancreatic cancer, oral squamous cell cancer, Acute myloid leukemia (AML), skin burn, skin scarring, skin aging, eye diseases such as vitreoretinal eye disease, and Macular degeneration, diabetes, obesity for medical use, namely, preparations containing novel RNA nanoparticle technologies; nanoparticle formulations for pharmaceutical, medical or medical diagnostic purposes, namely, RNA packaged lipid and extravesicular nanoparticles; backbone modified conjugated RNAs, drug delivery agents for medical use consisting of RNA nanoparticle formulations that facilitate delivery of a wide range of pharmaceuticals; pharmaceutical preparations comprising drug delivery agents based on RNA nanoparticle formulations; pharmaceutical preparations, namely, RNA and delivery agents comprised of nanoparticle carriers and polymers for the delivery of RNA to human cells

Custom manufacture of pharmaceutical products including manufacture of pharmaceutical preparations containing RNA, nucleic acids, protein nanoparticles; providing information in the field of custom manufacture of pharmaceuticals

Chemical, biological, and bacteriological preparations, other than for medical or veterinary use, for scientific and research use, or for the manufacture of pharmaceuticals; chemical, biological, and bacteriological preparations for scientific and research use, or for the manufacture of pharmaceuticals, namely, preparations containing RNA nanoparticle technologies; RNA nanoparticles, namely, RNA packaged lipid nanoparticles, RNA packaged cell derived extracellular vesicles, chemically modified RNAs capable of naked delivery for scientific, laboratory or medical research use